Micropulse Laser Photocoagulation in Diabetic Macular Edema
ConditionDiabetic Macular Edema
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorSohag University
About this trial
To assess the safety and efficacy of 532 nm subthreshold micropulse laser 5 % duty cycle compared with 15 % duty cycle in treatment of diabetic macular edema .
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Are More than 18 years old .
have diabetic macular edema with a central retinal thickness < 400 um .
have best corrected visual acuity between 6/18 and 6/60 .
Disqualifiers
Previous lasered retina , Anti - VEGF injection or vitrectomy .
Extensive Macular ischemia on FFA .
Media opacity .
Associated ocular pathology as glaucoma, CNV (choroidal neovascularization ) , AMD (age related macular degenerations ), epiretinal membrane vitreomacular traction and retinal vein occlusion .
Trial design
Design model
Parallel
Treatments tested in this trial
micropulse laser photocoagulation
Procedure/Surgerymicropulse laser photocoagulation in treatment of diabetic macular edema, 5% duty cycle
micropulse laser photocoagulation
Procedure/Surgerymicropulse laser photocoagulation in treatment of diabetic macular edema,15% duty cycle
Treatment groups
50 Participants
are divided into 2 treatment groupsGroup A: group AActive comparator 1 intervention
Group B: Group BActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
central macular thickness
assessment of change of central macular thickness before and after laser treatment
Time frame
3 monthsLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: